about
Stenting versus endarterectomy for treatment of carotid-artery stenosis.Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry fundingHealth-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial.Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials.Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model.Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phaseCutting balloon to treat carotid in-stent stenosis: technical note.Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial.Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial.ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on ClinCredentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST.Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interMediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique.Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy.Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.Cardiovascular care for older adults: hypertension and stroke in the older adultVascular disease in the older adult.Agreement between site-reported and ultrasound core laboratory results for duplex ultrasound velocity measurements in the Carotid Revascularization Endarterectomy versus Stenting TrialThe decline in PCI complication rate: 2003-2006 versus 1999-2002.Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks.Carotid artery stenting: a clinical update.Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients With Symptomatic Stenosis of the Internal Carotid Artery: Results From 4 Randomized Controlled Trials.Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.Asymptomatic carotid stenosis: Medicine alone or combined with carotid revascularization.Body mass index and outcome after revascularization for symptomatic carotid artery stenosis.MANTA, a novel plug-based vascular closure device for large bore arteriotomies: technical report.Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.Interventional cardiologists: Beware and be aware: An updated report of radiation-induced cutaneous cancers.One-year clinical outcomes, midterm survival, and predictors of mortality after carotid stenting in elderly patients.Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors.Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?Predictors of restenosis after successful carotid artery stenting.Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial.
P50
Q24619941-E3807F00-9BF6-4ED6-AB37-F6989EF0591AQ24793289-DCFBD516-2A25-4F3F-A20F-BC449C000909Q28249316-F0BCBF9F-A6F0-422F-BAEC-C1F638E3EE19Q30414911-738AB3E9-1E18-4F6C-9E00-207721E72C42Q31046129-FE1DAE66-DE69-41C8-B2E5-E9EAA357A324Q33959229-6B15D231-CBC4-4A95-AA28-097ED3F5D09CQ34033269-E39A9A79-5598-43B3-AC66-9393A01266D5Q34102771-FD6D56C5-B6C2-40D0-AD28-792268C915C3Q35096062-4BC3DAFB-A895-406A-A996-8A4CC400D3C2Q35214702-BD98E297-8B41-40DF-8022-DFF26A8C795FQ35853183-49CE5011-1D1F-42A7-982F-B7A4DEE43E24Q35863551-BCC2D8AE-BC8A-4C63-8441-5027C04F76DAQ35959408-4F5A8804-DF59-47B8-AA20-C1E7B0828314Q35998259-5D83ED85-6AB2-4B8E-92EE-2F1DF79FC33FQ36198690-6B8881E1-6A1A-4B05-88B8-CFD92235D202Q36459007-D18E98BA-9564-44E4-94D8-20AF2B240BB0Q36763689-417E81C0-0AD9-46D2-9AD2-95F81500AED9Q36921655-A45AC666-D307-4E8E-A786-EE6F97245265Q37174274-9FC124F3-DCD7-40C6-AF8E-664D5F3D6A42Q37437828-4983C0B4-1A61-4022-8D2C-F4F4B704B15CQ37552174-40BDC128-25DB-40D9-A56A-3D16C36CE71FQ37600511-53FDB323-C752-464F-ADC9-C3BC0C199B38Q37955351-B6A66D99-D0D9-4BDD-AB2B-8E66A3DCBA8AQ38039893-A39AA08B-738F-4D96-A259-346C628B632BQ38372823-A18DA840-B03B-4B66-8799-2440A6064411Q38377364-D8DE8F81-1492-47F9-998A-5BC57829DE49Q38566789-4ECF7E9E-1EC2-4682-B4D9-6DFF700A3154Q38817998-B7C764B9-0918-4E6F-AF31-EAE406D04422Q38818005-41FC081F-6618-446C-B045-2E48387383E4Q39378195-3A3B21A1-C63A-418B-80B2-DBF2ADD69743Q40219352-DC0AFF43-75FA-498F-BACB-3E0D421E4D4CQ42517009-1407C637-B8B1-448B-A343-1BEE4ADF6550Q43419896-4DCC231F-7719-4034-A511-DE421B53DA64Q43957429-043243C6-F536-4B97-BCC7-05E925DFDFB6Q44161865-4FF9A989-64DF-4831-B9F0-DF9D53B403C0Q44384638-7B96905D-5FE0-4E2E-97DB-01CE28127AD1Q44421477-75B4D269-486F-49AA-B3FA-11B3511ECF1CQ44452972-E2D44EF1-F89B-4ED5-B99C-62CEC77C2F9AQ44776900-A642837C-C8B1-45F9-B9B4-B951408C28B0Q44803696-83CBD416-3C96-4862-9682-1927AB103DC8
P50
name
Gary S Roubin
@en
type
label
Gary S Roubin
@en
prefLabel
Gary S Roubin
@en